Learn about impactful innovations as well as new startup companies generated from Abigail Wexner Research Institute at Nationwide Children’s Hospital. Join us for talks highlighting novel interventions from Nationwide Children’s researchers.

Join us in-person or via livestream for a conversation about the tremendous growth in the Cell and Gene Therapy field. Please make reservations by Tuesday, March 15th. We cannot accommodate walk-ins. The event is presented by Columbus Metropolitan Club, hosted by Eddie Pauline, BioOhio President & CEO, and features • Timothy J. Miller, Ph.D.,CEO, President and Co-Founder, Forge Biologics • BioOhio Board Member Eli Phillips Jr., PharmD, Vice President for Specialty Solutions, Cardinal Health • Samantha M. Jaglowski, M.D., Associate Professor of Hematology, Medical Director of the Blood and Marrow Transplant Program, and member of the Leukemia Research Program, The James Comprehensive Cancer Center at The Ohio State University.

With the EU Medical Device Regulation (MDR) now fully applicable, manufacturers are facing the challenges of both transitioning legacy devices to the MDR, and introducing new products. Although the Medical Device Coordination Group (MDCG) guidance has been forthcoming, there remain significant gaps in guidance and interpretation of requirements, and varying interpretations of expectations. In addition with the limited number of Notified Bodies designated under the MDR, there is substantial pressure to make MDR submissions as soon as possible to avoid the “cliff edge” of May 2024. NAMSA invites you to join this upcoming webinar as our team of regulatory experts discuss practical insights to address these challenges.

The Conference on Innovations in Climate Resilience, presented by Battelle in collaboration with DOE National Laboratories, offers a curated technical program with invited keynote presentations, platform and lightning talks and a poster reception. We’re expecting an audience of government leaders, entrepreneurs and innovators to explore breakthroughs in technology, science, policy and infrastructure that will help mitigate the threats to our environment, health, communities, national security and economic well-being from a changing climate.

Join JumpStart for the next episode of Founders Unfiltered featuring Afif Ghannoum, co-founder of BIOHM Health. Afif, a biotechnology attorney by training, co-founded BIOHM with his father Dr. Mahmoud Ghannoum, a global leader in medical mycology and Case Western Reserve University Professor. The father and son duo launched BIOHM in 2016 to help bring Dr. Ghannoum’s science to consumers, commercializing probiotics and microbiome testing kits to target fungi and bacteria in the digestive tract. JumpStart will talk to Afif about BIOHM’s recent funding round, the results of their groundbreaking clinical trials and his work commercializing healthcare innovation.

The Association of Food and Drug Officials (AFDO) and the Regulatory Affairs Professionals Society (RAPS) have come together to support sharing, collaboration, and learning across the global healthcare products community. With a focus on fostering open discussions of the most pressing issues facing the industry, the AFDO/RAPS Healthcare Products Collaborative will carry on Xavier Health’s legacy of delivering the MedCon Conference.

This annual conference brings together leading authorities from FDA, industry and academia to address the latest statistical trends and issues facing medtech organizations. In an effort to provide quality programming in the safest and most effective manner possible, the Conference will once again be held virtually this year. Dates: Wednesday, May 11th – Friday, May 13th

ARM, in partnership with BioOhio and JobsOhio, will hold its first state event in Columbus in May, showcasing Ohio’s leadership in creating a hub for the cell and gene therapy field. The event will include a panel discussion from 4:00 pm – 5:00 pm, followed by a reception from 5:00 pm – 7:00 pm.

Harrington Discovery Institute accelerates promising discoveries into medicines for unmet needs focusing on Major Diseases, Brain Health Medicines, COVID-19, and Rare Diseases. Our work endeavors to improve human health and better our world. We are driven by passion, innovation, and integrity, to cure diseases together.

Join NAMSA for this webinar as we walk through the key differences between EU’s In Vitro Diagnostic Directive (IVDD) and IVDR and the clinical study requirements outlined within these regulations. We will also examine ISO 20916:2019 as the Good Clinical Practice (GCP) guidance for IVD clinical performance.